Ikarian Capital, LLC Cel Sci Corp Put Options Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2020 Nov 16, 2020	SELL	$11.69 - $14.54 $7.45 Million - $9.27 Million	-637,700 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$9.75 - $17.6 $1.34 Million - $2.42 Million	137,700 Added 27.54%	637,700 $9.51 Million
Q1 2020 May 15, 2020	BUY	$7.54 - $17.05 $1.51 Million - $3.41 Million	199,800 Added 66.56%	500,000 $5.77 Million
Q4 2019 Jan 31, 2020	BUY	$6.71 - $9.55 $2.01 Million - $2.87 Million	300,200 New	300,200 $2.75 Million

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26.9M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.